MENU
+Compare
OZEM
ETF ticker: NASDAQ
AS OF
Sep 25 closing price
Price
$26.51
Change
-$0.87 (-3.18%)

OZEM stock forecast, quote, news & analysis

The investment seeks to provide capital appreciation... Show more

Category: #Health
OZEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
These past five trading days, the ETF lost 0.00% with an average daily volume of 0 shares traded.The ETF tracked a drawdown of 0% for this period.
Interact to see
Advertisement
A.I.Advisor
a Summary for OZEM with price predictions
Sep 24, 2025

Momentum Indicator for OZEM turns positive, indicating new upward trend

OZEM saw its Momentum Indicator move above the 0 level on September 18, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 16 similar instances where the indicator turned positive. In of the 16 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for OZEM just turned positive on September 18, 2025. Looking at past instances where OZEM's MACD turned positive, the stock continued to rise in of 10 cases over the following month. The odds of a continued upward trend are .

OZEM moved above its 50-day moving average on August 26, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for OZEM crossed bullishly above the 50-day moving average on August 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 4 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where OZEM advanced for three days, in of 85 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 44 cases where OZEM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for OZEM moved out of overbought territory on September 23, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 7 similar instances where the indicator moved out of overbought territory. In of the 7 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 3 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where OZEM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

OZEM broke above its upper Bollinger Band on September 22, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Eli Lilly & Co (NYSE:LLY), AstraZeneca PLC (NASDAQ:AZN), Amgen (NASDAQ:AMGN), Gilead Sciences (NASDAQ:GILD), Pfizer (NYSE:PFE), Regeneron Pharmaceuticals (NASDAQ:REGN).

Industry description

The investment seeks to provide capital appreciation. The fund's manager will invest at least 80% of its net assets (plus any borrowings for investment purposes) in the equity securities of GLP-1 & Weight Loss Companies or any derivative instruments (such as swap agreements or forward contracts) that utilize one or more GLP-1 & Weight Loss Companies as the reference asset. The fund is non-diversified.

Market Cap

The average market capitalization across the Roundhill GLP-1 & Weight Loss ETF ETF is 91.04B. The market cap for tickers in the group ranges from 345.97M to 640.6B. LLY holds the highest valuation in this group at 640.6B. The lowest valued company is ALT at 345.97M.

High and low price notable news

The average weekly price growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was -2%. For the same ETF, the average monthly price growth was 3%, and the average quarterly price growth was 12%. GPCR experienced the highest price growth at 8%, while BHVN experienced the biggest fall at -11%.

Volume

The average weekly volume growth across all stocks in the Roundhill GLP-1 & Weight Loss ETF ETF was -19%. For the same stocks of the ETF, the average monthly volume growth was -0% and the average quarterly volume growth was 28%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 46
P/E Growth Rating: 80
Price Growth Rating: 55
SMR Rating: 69
Profit Risk Rating: 74
Seasonality Score: -43 (-100 ... +100)
View a ticker or compare two or three
OZEM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details